Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis

Adjuvant interferon (IFN) therapy following curative treatment for hepatocellular carcinoma (HCC) has been extensively investigated; however, the clinical benefits with different hepatitis backgrounds remain unclear. Medline, Embase, PubMed and the Cochrane Library databases were searched to identif...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: ZHANG, WEI, SONG, TIAN-QIANG, ZHANG, TI, WU, QIANG, KONG, DA-LU, LI, QIANG, SUN, HUI-CHUAN
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179807/
https://ncbi.nlm.nih.gov/pubmed/25279210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.386
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller